Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional chinese medicine RCTs: A review of 3159 RCTs identified from 260 systematic reviews

Trials

Volumn 12, Issue , 2011, Pages

  He, Jia ^a   Du, Liang ^a   Liu, Guanjian ^a   Fu, Jin ^b   He, Xiangyu ^b   Yu, Jiayun ^b   Shang, Lili ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT;

ACUPUNCTURE; ARTICLE; CHINESE MEDICINE; CLINICAL RESEARCH; HUMAN; MASSAGE; MEDICAL LITERATURE; PUBLICATION; QUALITY CONTROL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); CHI SQUARE DISTRIBUTION; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; METHODOLOGY; PATIENT SELECTION; REPRODUCIBILITY; REVIEW; SINGLE BLIND PROCEDURE; STANDARD; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; EVIDENCE-BASED MEDICINE; HUMANS; MEDICINE, CHINESE TRADITIONAL; PATIENT SELECTION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 79955831709     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-122     Document Type: Article

References (32)

1. Wang G, Mao B, Xiong ZY, et al. The quality of reporting of randomized controlled trails of Traditional Chinese Medicine: A survey of 13 randomly selected journals from mainland China. Clinical Therapeutics 2007, 29:1457.
2. Lai SL, Hu JQ, Guo XF. Evidence-Based Medicine and Clinical Studies of Traditional Chinese Medicine. Journal of Guangdong University of Traditional Chinese Medicine 2000, 17(3):1-8.
3. Liu JP, Xia Y. Quality Appraisal of Systematic Reviews or Meta-analysis on Traditional Chinese Medicine Published in Chinese Journals. Chinese Journal of Integrative Medicine 2007, 27(4):306-308.
4. Chen WH, Liu DB, Zhou W, et al. Symptomatology in Evidence-based Traditional Chinese Medicine. Chinese Archives of Traditional Chinese Medicine 2005, 23(3):456-447.
5. Sackett DL, Richardson WS, Roseberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach. New York: Churchill Livingstone 1997,
6. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: Synthesis of best evidence for Clinical decisions. Annals Internal Medicine 1997, 126:376-380.
7. Bian ZX, Li YP, David M, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. Journal of Chinese Integrative Medicine 2006, 4:121.
8. Peter J, Altman DG, Matthias E. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42. 10.1136/bmj.323.7303.42, 1120670, 11440947.
9. Gluud LL. Bias in clinical intervention research. American Journal of Epidemiology 2006, 163:493-501. 10.1093/aje/kwj069, 16443796.
10. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273(5):408-412. 10.1001/jama.273.5.408, 7823387.
11. Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta- analyses?. Lancet 1998, 352(9128):609-613. 10.1016/S0140-6736(98)01085-X, 9746022.
12. Wood L, Egger M, Gluud LL, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336(7644):601-605. 10.1136/bmj.39465.451748.AD, 2267990, 18316340.
13. Kunz R, Vist G, Oxman AD. Randomisation to protect against selection bias in healthcare trials. Cochrane Database of Systematic Reviews 2007, (2).
14. Kunz R, Oxman AD. The unpredictability paradox: rovicw of empirical comparisons of randomized and non-randomized clinical trials. BMJ 1998, 317:1185-1190. 28700, 9794851.
15. Li J. Allocation Concealment: Why and How?. Chinese Journal of Evidence-based Medicine 2004, 4(10):714-715.
16. Schulz KF, Chalmers I, Grimes DA, et al. Assessing the quality of randomization from reports of controlled trials published in obstertrics and gynecology in journals. JAMA 1994, 272:125-128. 10.1001/jama.272.2.125, 8015122.
17. Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions.Version 5.0.1 [updated September 2008]. The Cochrane Collaboration 2008, Higgins JPT, Green S., http://www.cochrane-handbook.org
18. WHO the Tenth Revision of the International Classification of Diseases (ICD-10). WHO.
19. Wu TX, Li YP, Bian ZX, et al. Randomized trials published in some Chinese journals: how many are randomized?. Trials 2009, 10:46. 10.1186/1745-6215-10-46, 2716312, 19573242.
20. Guan ZH. Acupuncture Medicine Research Progress and Prospects at Home and Abroad. Yunnan Journal of Traditional Chinese Medicine and Materia Medica 2000, 21(1):7-8.
21. Lao LX. Evidence-based medicine in acupuncture. World Journal of Acupuncture-Moxibustion 2007, 17(4):1.
22. Begg CB, Cho MK, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996, 276:637-639. 10.1001/jama.276.8.637, 8773637.
23. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001, 134:663-694.
24. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869, 2844943, 20332511.
25. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. The Medical journal of Australia 2006, 185(5):263-267.
26. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 2005, 330:1056-1057. 10.1136/bmj.330.7499.1056, 557224, 15879389.
27. Moher D, Jones A, Lepage L, . for the CONSORT Group Use of the CONSORT statement and quality of reports of randomized trials: a comparative before and after evaluation?. JAMA 2001, 285:1992-1995. 10.1001/jama.285.15.1992, 11308436, for the CONSORT Group.
28. Hopewell S, Altman DG, Moher D, et al. Endorsement of the CONSORT Statement by high impact medical journals-survey of journal editors and journal 'Instructions to Authors'. Trials 2008, 9:20. 10.1186/1745-6215-9-20, 2359733, 18423021.
29. Xu L, Li J, Zhang MM, et al. Chinese authors do need CONSORT: Reporting quality assessment for five leading Chinese medical journals. Contemporary Clinical Trials 2008, 29:727-731. 10.1016/j.cct.2008.05.003, 18579449.
30. Wang L, Li YL, Li J. Quality of reporting of trial abstracts needs to be improved: using the CONSORT for abstracts to assess the four leading Chinese medical journals of traditional Chinese medicine. Trials 2010, 11:75. 10.1186/1745-6215-11-75, 2911423, 20615225.
31. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement. PLoS Medicine 2010, 7(6):e1000261. 10.1371/journal.pmed.1000261, 2882429, 20543992.
32. Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Annals of Internal Medicine 2006, 144(5):364-367.